Sandimmun (ciclosporin A) treatment of chronic glomerulonephritis with
nephrotic syndrome in a dose 2.5-5 mg/kg for 6-10 months relieved nep
hrotic syndrome in 2 and resulted in clinical improvement in other 2 o
f 4 patients treated. In 3 cases the patients failed previous therapy
with high-dose corticosteroids and cytostatics. The drug reduced prote
inuria, elevated serum levels of albumin and total protein, had low ne
phrotoxicity.